About Homie

Homie Razavi is the founder and managing director at the Center for Disease Analysis (CDA), an organization specializing in studying complex and poorly understood diseases. CDA’s goal is to study and publish data to help educate stakeholders and support decision-making in different countries.

Since 2008, Homie has led a team of epidemiologists and modellers to quantify epidemiology of hepatitis C virus (HCV) and forecast the future impact of HCV disease burden. They have analyzed HCV disease burden in over seventy countries and have helped countries develop national strategies. CDA has been responsible for the development of a number of mathematical models currently used by countries to develop intervention strategies for HCV and HBV:
HCV disease progression
HCV transmission
HCV economic impact
HBV vertical transmission; economic impact
HBV disease progression/treatment; economic impact

In addition, CDA has developed the Polaris Observatory, which collects and reports HCV, HBV and HDV epidemiology, disease burden and treatment rate annually. He has a broad background, which includes basic research, commercial development, portfolio management, and decision analysis. He is also a fellow in the Society of Decision Professionals.

This speaker will be presenting at the following session(s)

  • Strategic direction 4: financing for sustainability

    Plenary

    Day: Friday 3

    Time: 09:30

    The first of two plenary sessions on strategic direction 4, which addresses the sustainable financing of hepatitis responses within a whole health systems approach.

    Presentations:

    • Financing for hepatitis within a whole health systems approach - a panel discussion.
      Dr Jeremy Lauer, World Health Organization 
      Dr David Wilson, World Bank
      Various national governments
    • Pooled procurement - PAHO's Strategic and Revolving Funds.
    • Pooled procurement - The new Global Procurement Fund.
      Dr Homie Razavi, Center for Disease Analysis

    Session objective:

    • Learn how countries can best approach sustainable financing for hepatitis.